UBS AM’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-110,752
| Closed | -$167K | – | 2636 |
|
|
2023
Q2 | $167K | Hold |
110,752
| – | – | ﹤0.01% | 2592 |
|
|
2023
Q1 | $167K | Hold |
110,752
| – | – | ﹤0.01% | 2592 |
|
|
2022
Q4 | $277K | Hold |
110,752
| – | – | ﹤0.01% | 2356 |
|
|
2022
Q3 | $467K | Hold |
110,752
| – | – | ﹤0.01% | 2369 |
|
|
2022
Q2 | $309K | Hold |
110,752
| – | – | ﹤0.01% | 2474 |
|
|
2022
Q1 | $634K | Sell |
110,752
-256
| -0.2% | -$1.46K | ﹤0.01% | 2369 |
|
|
2021
Q4 | $1.01M | Buy |
111,008
+13,069
| +13% | +$119K | ﹤0.01% | 2206 |
|
|
2021
Q3 | $1.05M | Sell |
97,939
-5,441
| -5% | -$58.2K | ﹤0.01% | 2141 |
|
|
2021
Q2 | $1.6M | Buy |
103,380
+4,811
| +5% | +$74.7K | ﹤0.01% | 1956 |
|
|
2021
Q1 | $1.6M | Buy |
98,569
+4,171
| +4% | +$67.6K | ﹤0.01% | 1850 |
|
|
2020
Q4 | $2M | Hold |
94,398
| – | – | ﹤0.01% | 1686 |
|
|
2020
Q3 | $1.4M | Buy |
94,398
+4,274
| +5% | +$63.3K | ﹤0.01% | 1697 |
|
|
2020
Q2 | $1.33M | Sell |
90,124
-918
| -1% | -$13.5K | ﹤0.01% | 1682 |
|
|
2020
Q1 | $1.07M | Sell |
91,042
-93
| -0.1% | -$1.09K | ﹤0.01% | 1670 |
|
|
2019
Q4 | $2.14M | Buy |
91,135
+1,988
| +2% | +$46.7K | ﹤0.01% | 1578 |
|
|
2019
Q3 | $1.65M | Buy |
89,147
+23,288
| +35% | +$431K | ﹤0.01% | 1702 |
|
|
2019
Q2 | $1.22M | Buy |
65,859
+8,280
| +14% | +$154K | ﹤0.01% | 1802 |
|
|
2019
Q1 | $1.41M | Buy |
57,579
+9,551
| +20% | +$233K | ﹤0.01% | 1680 |
|
|
2018
Q4 | $1.25M | Buy |
48,028
+8,248
| +21% | +$214K | ﹤0.01% | 1653 |
|
|
2018
Q3 | $1.26M | Buy |
39,780
+5,710
| +17% | +$181K | ﹤0.01% | 1715 |
|
|
2018
Q2 | $1.32M | Buy |
34,070
+7,967
| +31% | +$310K | ﹤0.01% | 1702 |
|
|
2018
Q1 | $720K | Buy |
26,103
+13,403
| +106% | +$370K | ﹤0.01% | 1882 |
|
|
2017
Q4 | $230K | Buy |
+12,700
| New | +$230K | ﹤0.01% | 2238 |
|
|
2016
Q4 | – | Sell |
-15,200
| Closed | -$262K | – | 2561 |
|
|
2016
Q3 | $262K | Hold |
15,200
| – | – | ﹤0.01% | 2336 |
|
|
2016
Q2 | $274K | Hold |
15,200
| – | – | ﹤0.01% | 2266 |
|
|
2016
Q1 | $289K | Hold |
15,200
| – | – | ﹤0.01% | 2233 |
|
|
2015
Q4 | $406K | Buy |
+15,200
| New | +$406K | ﹤0.01% | 2167 |
|